Sneaky Cases of Allergic Contact Dermatitis
We all think about allergic contact dermatitis when a patient presents with a classic well-demarcated distribution of eczematous, pruritic rash. But under what other clinical scenarios should we consider the diagnosis of allergic contact dermatitis? At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Jonathan Zippin discussed three different clinical conundrums that should …
We all think about allergic contact dermatitis when a patient presents with a classic well-demarcated distribution of eczematous, pruritic rash. But under what other clinical scenarios should we consider the diagnosis of allergic contact dermatitis? At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Jonathan Zippin discussed three different clinical conundrums that should … Continue reading "Sneaky Cases of Allergic Contact Dermatitis"
Platelet-rich plasma or PRP, derived from the patient’s own blood, is considered by many to be an all-natural, safe product with rejuvenation properties. Here, we discuss what exactly is PRP, the qualities that would make an ideal PRP extraction system, and the work that lies ahead to standardize current treatment protocols.
Dr. Terrence Keaney led a lecture on platelet-rich plasma (PRP) at t … 
Who’s afraid of the Big Bad Wolves in pediatric dermatology? Whether in clinic or in the wards, we all have some bad wolves we hope not to encounter, and others that do not fail to surprise dermatologists. Here, I share a few of them as presented by Dr. Yasmine Kirkorian at the 2020 ODAC Dermatology, Aesthetic and Surgical Conference, including Mycoplasma-induced Rash and Mucositis (MIRM), Sta … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i … 
Melanoma remains the most common cause of death among skin cancers. Over the past decade, major leaps have been made in treating advanced melanoma, resulting in unprecedented improvement in survival. Nevertheless, a large room for improvement is still ahead. In his presentation Therapeutic Updates in Melanoma: IO for Earlier Stage Disease presented at the 2020 ODAC Dermatology, Aesthetic and Sur … 